Anjarium BioSciences
Schlieren, Switzerland · $61.0M raised
- Headquarters
- Schlieren
- Employees
- 11–50
- Business Model
- B2B
- Website
- anjarium.com
- Total Funding
- $61.0M
- Last Round
- $61.0M Series ASep 2021
- Rounds
- 1
About
Anjarium Biosciences is a Swiss cell and gene therapy tools company enabling next-generation gene therapies through proprietary delivery platforms.
Summary
Anjarium BioSciences is a Biotech company based in Schlieren, Switzerland. It has raised $61.0M in total across 1 round, most recently a $61.0M Series A round in Sep 2021. Investors include Gimv, Omega Funds and Pfizer Ventures.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2021
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company